Medically reviewed by Dr Itender Pal Singh
If you get migraine attacks regularly, there is an important reason to revisit the way you think about treatment.
For years, many people with frequent migraine attacks have simply treated each episode when it happened. Take a painkiller, lie down in a dark room, wait for the nausea and head pain to settle, and hope the next attack comes later.
But what if the better approach is to prevent some of those attacks from happening in the first place?
New 2026 recommendations from the American Academy of Neurology (AAN) and the American Headache Society (AHS) have updated the approach to preventing migraine in adults. The recommendations replace the previous 2012 guidance and include a much wider range of preventive treatments.
The biggest message is simple: frequent or disabling migraine should not always be managed by treating one attack at a time.
For some adults, preventive treatment may now deserve a serious discussion with a healthcare professional.
In This Article:-
Too Many People Are Treating Migraine Only After It Starts
A migraine is more than an ordinary headache.
It is a neurological condition that can cause severe or throbbing head pain, often accompanied by nausea, vomiting, sensitivity to light or sound, dizziness, visual symptoms, or difficulty concentrating.
An attack can last for hours or even several days.
For a person experiencing occasional attacks, treating symptoms when they appear may be enough. But the situation changes when migraine becomes frequent.
Imagine someone who gets disabling migraine attacks every week.
They may miss work.
They may cancel plans.
They may avoid exercise, travel or social events because they are worried another attack could begin.
Eventually, the problem is no longer simply the pain itself. It is the uncertainty surrounding the next attack.
That is where preventive treatment can become important.
When Should You Consider Migraine Prevention?
The updated AAN-AHS guideline recommends that clinicians offer preventive treatment to adults who experience:
- 4 or more migraine days per month
- 4 or more moderate-to-severe headache days per month
- Or substantial disability caused by migraine
The recommendations are based on evidence that preventive medicines can reduce headache frequency and improve quality of life.
This does not mean that everyone with four migraine days automatically needs medication.
Instead, it means that four or more days per month is an important point at which prevention should be discussed.
That distinction matters.
Treatment should be based not only on the number of headache days but also on how strongly migraine affects a person’s daily life.
Why the New Migraine Guidelines Matter
The previous major AAN-AHS prevention guideline was published in 2012.
A lot has changed since then.
New migraine-specific treatments have been developed, particularly medicines that target the calcitonin gene-related peptide (CGRP) pathway.
CGRP is involved in the biological processes associated with migraine, and medicines targeting this pathway have become an important part of modern migraine prevention.
The 2026 guideline therefore gives clinicians a broader menu of options rather than relying mainly on older preventive medications.
That is particularly important for people who tried an older medicine and stopped because it did not work well or caused troublesome side effects.
One failed treatment does not mean that every preventive treatment will fail.
What Treatments Can Be Used to Prevent Migraine?
The new guideline does not recommend one universal medication for everybody.
Instead, the best choice depends on the person’s circumstances.
For episodic migraine, treatments with higher or moderate confidence in their effectiveness include medicines such as:
- Atogepant
- Eptinezumab
- Erenumab
- Fremanezumab
- Galcanezumab
- Propranolol
- Topiramate
- Valproate
For chronic migraine, options with higher or moderate confidence in the evidence include:
- Atogepant
- Eptinezumab
- Erenumab
- Fremanezumab
- Galcanezumab
- OnabotulinumtoxinA
- Topiramate
- Valproate
The guideline also includes other preventive medicines that may be considered depending on the individual situation.
The important point is that migraine prevention is becoming more personalized.
Newer Migraine Medicines Are Changing the Treatment Conversation
One of the biggest developments in migraine treatment has been the arrival of CGRP-targeting therapies.
These include CGRP monoclonal antibodies such as:
- Erenumab
- Fremanezumab
- Galcanezumab
- Eptinezumab
There are also oral CGRP-targeting medicines known as gepants, including atogepant and rimegepant.
The American Headache Society’s 2024 position statement concluded that CGRP-targeting therapies can be considered first-line options for migraine prevention rather than requiring patients to fail several older preventive medicines first.
The 2026 AAN-AHS guideline also places several CGRP-targeting treatments among the options with strong or moderate evidence.
That represents a major shift from the treatment landscape of more than a decade ago.
But There Is No “Best” Migraine Medicine for Everyone
This may be one of the most important messages from the new recommendations.
Two people can have a similar number of migraine days and still need completely different treatment plans.
Why?
Because doctors need to consider more than headache frequency.
The guideline recommends considering factors such as:
- How effective the treatment is expected to be
- Potential side effects
- Tolerability
- Cost
- Access to the medicine
- How the medicine is administered
- Other medical conditions
- The person’s preferences
- The impact of migraine on quality of life
For example, someone who already has another medical condition may benefit from a preventive medicine that could potentially address more than one problem.
Someone else may prioritize avoiding particular side effects.
Another person may be unable to afford an expensive medication.
So the “best” migraine treatment is not necessarily the newest one. It is the option that offers a reasonable balance between effectiveness, safety, tolerability, access and the person’s individual needs.
What Is Episodic vs. Chronic Migraine?
The distinction matters when choosing preventive treatment.
According to the updated guidance, chronic migraine involves headaches on at least 15 days per month for more than 3 months, with migraine features on at least 8 of those days.
People with fewer headache days may fall into the episodic migraine category.
This classification helps clinicians choose appropriate treatments and assess how severe the problem has become.
It also shows why keeping track of headache days can be useful.
A Simple Example: Why Counting Migraine Days Matters
Consider a person who experiences headaches on 10 days each month.
On six of those days, the symptoms include throbbing head pain, nausea and sensitivity to light.
They also miss work several times a month.
Simply saying “I get headaches” does not communicate the full picture.
A headache diary could show:
10 headache days/month → 6 migraine days → several missed workdays → significant disruption
That information can help a clinician determine whether preventive treatment should be considered and whether the treatment is actually working after it begins.
The new guideline specifically emphasizes monitoring treatment response and adverse effects after starting preventive treatment.
Don’t Wait for Migraine to Control Your Life
Preventive treatment is different from medication taken during an acute migraine attack.
Acute treatment is generally used when an attack occurs.
Preventive treatment is used regularly to reduce the frequency or severity of future attacks.
Depending on the medication, preventive therapy may involve an oral medicine taken regularly or an injectable treatment given monthly or at longer intervals.
The choice depends on the treatment and the individual patient.
The goal is not necessarily to eliminate every migraine forever.
Instead, prevention aims to reduce the burden of the condition.
Fewer migraine days can mean fewer missed workdays, fewer disrupted plans and less dependence on acute medications.
What If Your First Migraine Preventive Treatment Doesn’t Work?
Don’t assume that you have run out of options.
The updated guideline recognizes that response varies from person to person.
A preventive medication may fail because it does not reduce attacks enough, because side effects become difficult to tolerate, or because another factor makes it unsuitable.
That does not automatically mean another treatment will fail.
Clinicians can reassess the situation and consider another preventive strategy.
This is one reason follow-up is so important.
Keep a Migraine Diary
A headache diary may sound simple, but it can provide useful information.
Record:
- The date of each attack
- How long it lasted
- Severity
- Associated symptoms
- Possible triggers
- Medicines taken
- How well the medicine worked
- Any side effects
- Missed work or daily activities
Over several weeks, patterns may become easier to identify.
A diary can also help your clinician determine whether preventive treatment is actually reducing migraine frequency.
What About Medication Overuse?
There is another important reason preventive treatment deserves attention.
People with frequent migraine may end up using acute headache medicines repeatedly.
The new guideline specifically recommends offering preventive medication to people who meet criteria for medication overuse or medication-overuse headache. It also identifies treatments with evidence in people experiencing medication overuse, including certain CGRP-targeting therapies, atogepant, onabotulinumtoxinA and topiramate.
This does not mean that everyone taking headache medicine frequently has medication-overuse headache.
But frequent use is something worth discussing with a healthcare professional.
Does Everyone With Migraine Need Preventive Medication?
No.
The new guideline does not say that every person with migraine should take preventive medicine.
Instead, it gives clinicians a clearer evidence-based framework for deciding when prevention may be appropriate.
Someone with occasional, manageable attacks may not need preventive medication.
But someone experiencing frequent attacks, significant disability or repeated disruption to everyday life may benefit from discussing prevention.
The decision should be individualized.
What Should You Ask Your Doctor?
If migraine is affecting your life regularly, consider asking:
“Should I be taking preventive treatment rather than only treating attacks when they happen?”
You can also ask:
- How many migraine days do I have each month?
- Which preventive options fit my medical history?
- What side effects should I expect?
- How long should we try the treatment?
- How will we know if it is working?
- Are CGRP-targeting treatments appropriate for me?
- Could another health condition affect the choice of medicine?
- What should I do if the first treatment does not work?
- Could I be experiencing medication-overuse headache?
These questions can turn a general headache conversation into a more useful treatment discussion.
The Bottom Line
The way doctors prevent migraine is changing.
The 2026 AAN-AHS guideline replaces the previous 2012 recommendations and recognizes the much larger range of preventive treatments now available.
Adults experiencing 4 or more migraine days per month, 4 or more moderate-to-severe headache days per month, or substantial disability from migraine should be considered for preventive treatment.
Newer CGRP-targeting therapies have expanded the options available to patients, while established medicines such as topiramate, propranolol and others remain important choices for appropriate patients.
But there is no single treatment that works best for everyone.
The right migraine prevention strategy should consider effectiveness, side effects, cost, other medical conditions, treatment preferences and quality of life.
If migraine is repeatedly taking you away from work, family, sleep or everyday activities, you do not necessarily have to keep treating each attack as an isolated event.
It may be time to talk about prevention.
Medical disclaimer: This article is for educational purposes and does not replace individualized medical advice. Do not start, stop or change a migraine medication without discussing it with a qualified healthcare professional.
Frequently Asked Questions
1. How Many Migraine Days Per Month Mean I Should Consider Preventive Treatment?
The 2026 AAN-AHS guideline recommends offering preventive treatment to adults with 4 or more migraine days per month, 4 or more moderate-to-severe headache days per month, or substantial disability caused by migraine.
2. What Is the Difference Between Migraine Treatment and Migraine Prevention?
Acute treatment is taken to manage an attack when it occurs. Preventive treatment is taken regularly with the goal of reducing the frequency or severity of future attacks.
3. What Are the Newest Migraine Prevention Medicines?
Several newer preventive treatments target the CGRP pathway. These include monoclonal antibodies such as erenumab, fremanezumab, galcanezumab and eptinezumab, along with oral CGRP-targeting medicines such as atogepant and rimegepant.
4. Are CGRP Medicines First-Line Options for Migraine Prevention?
The American Headache Society’s 2024 position statement supports CGRP-targeting therapies as first-line options for migraine prevention. The 2026 AAN-AHS guideline also lists several CGRP-targeting treatments among options with strong or moderate evidence.
5. What Is Chronic Migraine?
Chronic migraine is generally defined as headache occurring on at least 15 days per month for more than 3 months, with migraine features on at least 8 of those days.
6. What If My Migraine Medicine Doesn’t Work?
A poor response or troublesome side effects from one preventive medicine do not necessarily mean other treatments will fail. Your clinician can reassess the diagnosis, treatment response and side effects and consider another option.
7. Can Migraine Preventive Treatment Help With Medication Overuse?
Preventive treatment may be appropriate for people with migraine who meet criteria for medication overuse or medication-overuse headache. The 2026 guideline identifies several preventive treatments with evidence in this setting.
8. Should I Keep a Migraine Diary?
Yes. Recording headache days, symptoms, severity, medicines used and treatment response can help both you and your clinician determine how often migraine occurs and whether preventive treatment is helping.
9. Does Everyone With Migraine Need Medication?
No. Preventive treatment is not automatically necessary for everyone. The decision depends on attack frequency, disability, medical history, treatment preferences, side effects, cost and other factors.
10. When Should I Talk to a Doctor About Migraine Prevention?
If migraine attacks are frequent, disabling, interfering with work or daily activities, or requiring frequent acute medication, it is reasonable to discuss preventive treatment with a healthcare professional.
Sources and Further Reading
1. American Academy of Neurology (AAN)
2026 Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline
https://www.neurology.org/doi/10.1212/WNL.0000000000214881
2. American Academy of Neurology (AAN)
Systematic Review of Pharmacologic Treatment for Migraine Prevention in Adults
https://www.neurology.org/doi/10.1212/WNL.0000000000218112
3. American Headache Society (AHS)
CGRP-targeting therapies as a first-line option for migraine prevention
https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14692
4. American Headache Society
https://americanheadachesociety.org
5. American Academy of Neurology
Medical Disclaimer: This article is intended for educational purposes only and should not replace professional medical advice, diagnosis or treatment. Anyone considering starting, stopping or changing migraine medication should discuss the decision with a qualified healthcare professional.
We have a very strict reviewing guidelines on how to run every article in the website. Everything we write follow a very strict reviewing process by following high quality peer-reviewed studies. Every source we follow are credible and accurate and again reviewed by our doctors to give you all high quality advise and content.
For the latest health trending topics and top of the line updated health and fitness related news and conditions with insights from board certified experienced health professionals, follow Healing Doctor on Facebook, Instagram and Whatsapp.
